Re: Sarcopenia is a Poor Prognostic Factor of Castration-Resistant Prostate Cancer Treated with Docetaxel Therapy

被引：0
|
作者：
Griebling, Tomas L.
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷 / 01期
关键词：
D O I：
10.1097/01.JU.0000604840.21681.4b
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [41] Re: Olaparib for Metastatic Castration-resistant Prostate Cancer
    Di Lorenzo, Giuseppe
    Autorino, Riccardo
    EUROPEAN UROLOGY, 2020, 78 (05) : 767 - 768
  • [42] Re: The Role of MicroRNA in Castration-Resistant Prostate Cancer
    Narter, Fehmi
    JOURNAL OF UROLOGICAL SURGERY, 2016, 3 (04): : 151 - 151
  • [43] Re: Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 202 (04): : 660 - 661
  • [44] Re: Olaparib for Metastatic Castration-resistant Prostate Cancer
    Cumberbatch, Marcus
    Condon, Benjamin
    Lawrentschuk, Nathan
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2021, 79 (02) : 319 - 320
  • [45] Re: Olaparib for Metastatic Castration-Resistant Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2020, 204 (04): : 877 - 878
  • [46] High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy
    Keisuke Shigeta
    Takeo Kosaka
    Shigehisa Kitano
    Yota Yasumizu
    Yasumasa Miyazaki
    Ryuichi Mizuno
    Toshiaki Shinojima
    Eiji Kikuchi
    Akira Miyajima
    Hitoshi Tanoguchi
    Shintaro Hasegawa
    Mototsugu Oya
    Annals of Surgical Oncology, 2016, 23 : 4115 - 4122
  • [47] High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy
    Shigeta, Keisuke
    Kosaka, Takeo
    Kitano, Shigehisa
    Yasumizu, Yota
    Miyazaki, Yasumasa
    Mizuno, Ryuichi
    Shinojima, Toshiaki
    Kikuchi, Eiji
    Miyajima, Akira
    Tanoguchi, Hitoshi
    Hasegawa, Shintaro
    Oya, Mototsugu
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (12) : 4115 - 4122
  • [48] HIGH ABSOLUTE MONOCYTE COUNT PREDICTS POOR CLINICAL OUTCOME IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER TREATED WITH DOCETAXEL CHEMOTHERAPY
    Shigeta, Keisuke
    Kosaka, Takeo
    Shinojima, Toshiaki
    Mizuno, Ryuichi
    Kikuchi, Eiji
    Mlyajima, Akira
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2016, 195 (04): : E310 - E310
  • [49] Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
    Ruiz, Belen Congregado
    Belenchon, Ines Rivero
    Cano, Guillermo Lendinez
    Lopez, Rafael Antonio Medina
    BIOMEDICINES, 2023, 11 (04)
  • [50] INTERMITTENT DOCETAXEL THERAPY FOR CASTRATION RESISTANT PROSTATE CANCER
    Kume, Haruki
    Nagata, Masayoshi
    Igawa, Yasuhiko
    Nishimatsu, Hiroaki
    Enomoto, Yutaka
    Nakagawa, Tohru
    Fujimura, Tetsuya
    Suzuki, Motofumi
    Homma, Yukio
    JOURNAL OF UROLOGY, 2013, 189 (04): : E320 - E321
12345